- Home
- CBL vs ELVN Comparison
CBL vs ELVN Comparison
Compare CBL & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CBL | ELVN |
|---|---|---|
| Founded | 1978 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 1993 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CBL | ELVN |
|---|---|---|
| Price | $37.10 | $16.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $45.00 | $41.20 |
| AVG Volume (30 Days) | 166.8K | ★ 838.8K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | ★ 4.89% | N/A |
| EPS Growth | ★ 297.30 | N/A |
| EPS | ★ 4.02 | N/A |
| Revenue | ★ $553,643,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.17 | ★ N/A |
| Revenue Growth | ★ 5.74 | N/A |
| 52 Week Low | $21.10 | $13.30 |
| 52 Week High | $38.67 | $25.37 |
Technical Indicators
Market Signals| Indicator | CBL | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 65.23 | 39.10 |
| Support Level | $37.32 | $15.71 |
| Resistance Level | $38.67 | $18.05 |
| Average True Range (ATR) | 0.73 | 1.40 |
| MACD | -0.09 | -0.22 |
| Stochastic Oscillator | 58.49 | 16.04 |
Price Performance
Historical ComparisonAbout CBL CBL & Associates Properties Inc.
CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.